Alessandro Grattoni

Papers

Total Citations

H-Index

About

Alessandro Grattoni is a pioneering researcher at the forefront of nanofluidic implantable technologies for long-acting drug delivery. His work centers on developing smart, implantable systems that can precisely control therapeutic release over extended periods, addressing critical challenges in personalized medicine. Grattoni’s major contributions include the design of robotic UV-Vis apparatuses for reliable, long-term characterization of drug release kinetics from nanochannels, as detailed in his 2014 paper (15 citations), which provides essential tools for validating device performance. He has also advanced the field through comprehensive reviews, such as his 2017 work (10 citations), which highlights the potential of nanofluidic implantables when integrated with robotics, microprocessing, and tissue engineering. Most notably, his 2023 paper (4 citations) introduces a groundbreaking concept: robotic self-modulation that senses fibrotic capsule formation and adjusts drug release accordingly, enhancing implant longevity and efficacy. Grattoni’s research bridges engineering and medicine, offering transformative solutions for chronic disease management. His innovative approach to combining soft robotics with nanofluidics positions him as a leader in next-generation implantable therapeutics, with his work cited for its practical impact on drug delivery device design and clinical translation.